Home

Faible produire Rester cd 47 Déclin Acrobaties Utile

CD47: role in the immune system and application to cancer therapy |  Cellular Oncology
CD47: role in the immune system and application to cancer therapy | Cellular Oncology

Regulation of CD47 expression in cancer cells - ScienceDirect
Regulation of CD47 expression in cancer cells - ScienceDirect

CD47: role in the immune system and application to cancer therapy |  Cellular Oncology
CD47: role in the immune system and application to cancer therapy | Cellular Oncology

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits  tumor growth through induction of phagocytosis and apoptosis in multiple  myeloma | Haematologica
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma | Haematologica

Cells | Free Full-Text | Targeting the CD47-SIRPα Axis: Present  Therapies and the Future for Cutaneous T-cell Lymphoma
Cells | Free Full-Text | Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis |  Nature
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis | Nature

Second “Don't Eat Me” Signal Identified in Cancer Cells, Points to New  Immunotherapies | The Stem Cellar
Second “Don't Eat Me” Signal Identified in Cancer Cells, Points to New Immunotherapies | The Stem Cellar

Vaccines | Free Full-Text | Anti-CD47 Monoclonal Antibody–Drug Conjugate: A  Targeted Therapy to Treat Triple-Negative Breast Cancers
Vaccines | Free Full-Text | Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and  Eradicate Non-Hodgkin Lymphoma: Cell
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma: Cell

CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
CD47/SIRPα pathway mediates cancer immune escape and immunotherapy

Antiphagocytic function of CD47 on red blood cells (RBCs). Young RBCs... |  Download Scientific Diagram
Antiphagocytic function of CD47 on red blood cells (RBCs). Young RBCs... | Download Scientific Diagram

CD47 | Majeti Lab | Stanford Medicine
CD47 | Majeti Lab | Stanford Medicine

Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes  tumor metastasis: Molecular Therapy - Oncolytics
Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis: Molecular Therapy - Oncolytics

Frontiers | Glioblastoma Immunotherapy Targeting the Innate Immune  Checkpoint CD47-SIRPα Axis
Frontiers | Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis

Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer  cells | Nature Communications
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells | Nature Communications

CD47 — Wikipédia
CD47 — Wikipédia

Role of CD47 in Hematological Malignancies | Journal of Hematology &  Oncology | Full Text
Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text

063CE: Anti-CD47 Testing Interference with Connie Westhoff -
063CE: Anti-CD47 Testing Interference with Connie Westhoff -

JCI - Oncogenic KRAS signaling drives evasion of innate immune surveillance  in lung adenocarcinoma by activating CD47
JCI - Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47

Monoclonal anti‐CD47 interference in red cell and platelet testing -  Velliquette - 2019 - Transfusion - Wiley Online Library
Monoclonal anti‐CD47 interference in red cell and platelet testing - Velliquette - 2019 - Transfusion - Wiley Online Library

CD47‐signal regulatory protein α signaling system and its application to  cancer immunotherapy - Murata - 2018 - Cancer Science - Wiley Online Library
CD47‐signal regulatory protein α signaling system and its application to cancer immunotherapy - Murata - 2018 - Cancer Science - Wiley Online Library

CD47: the next checkpoint target for cancer immunotherapy - ScienceDirect
CD47: the next checkpoint target for cancer immunotherapy - ScienceDirect

CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio

Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer
Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer

CD47-related Signaling Pathways & Research Progress on the Relationship  with Related Diseases (Part Two) – Creative Biolabs Blog
CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two) – Creative Biolabs Blog

CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and  diabetes | American Journal of Physiology-Cell Physiology
CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes | American Journal of Physiology-Cell Physiology

Leukocyte Surface Antigen CD47 - ACROBiosystems
Leukocyte Surface Antigen CD47 - ACROBiosystems